
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Constellation Pharmaceuticals is dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Headlines from Mass High Tech about CONSTELLATION PHARMACEUTICALS
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2008 |
| Ownership Type | Private |
| No. of Employees at this location | Subscriber access only |
| Total Number Employees | Subscriber access only |
| Foreign Distribution | Subscriber access only |
| Mark Goldsmith | President/CEO | |||
| James Audia | CSO | |||
| Garen Bohlin | EVP | |||
| Michael Cooper | Chief Medical Officer/SVP | |||
| Brenda Sousa | VP Human Resources |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Size | Subscriber access only |
| Website | http://www.constellationpharma.com |
| Revenue | Subscriber access only |
| Address | 215 First St Suite 200 Cambridge, MA, 02142 |
| Phone | 617-714-0555 |
| Fax | 617-661-5382 |
| Subscriber access only | |
| Website | www.constellationpharma.com |